Table 1

List of Indicators Used to Measure Quality of Diabetes Care

Indicator	Short Name	Description (% Patients)	Type of Indicator
DM02	BMI record	Whose notes record body mass index	Process of care
DM10	Neuropathy testing	With a record of neuropathy testing	Process of care
DM13	Microalbuminuria record	Who have a record of microalbuminuria testing (except reporting for patients with proteinuria)	Process of care
DM15	ACE inhibitor	With a diagnosis of proteinuria or microalbuminuria who are treated with ACE inhibitors (or angiotensin II receptor blockers)	Process of care
DM18	Influenza immunization	Who have had influenza immunization	Process of care
DM21	Retinal screening	Who have a record of retinal screening	Process of care
DM22	Renal function record	Who have a record of estimated glomerular filtration rate or serum creatinine testing	Process of care
DM29	Foot risk	With a record of foot examination and risk classification: (1) low risk (normal sensation, palpable pulses), (2) increased risk (neuropathy or absent pulses), (3) high risk (neuropathy or absent pulses plus deformity or skin changes or previous ulcer), or (4) ulcerated foot	Process of care
DM17	Cholesterol ≤193.05 mg/dL (≤5 mmol/L)	Whose last measured total cholesterol was 193.05 mg/dL (≤5 mmol/L) or lower	Intermediate outcome
DM26	Diabetes control (HbA_1c = 7.5%)	In whom the last IFCC-HbA_1c reading was 59 mmol/mol (equivalent to HbA_1c of 7.5% in DCCT-derived units) or lower	Intermediate outcome
DM31	BP ≤140/80 mm Hg	In whom the last blood pressure reading was 140/80 mm Hg or lower	Intermediate outcome

ACE = angiotensin-converting enzyme; BMI = body mass index; BP = blood pressure; DCCT = Diabetes Control and Complications Trial; DM = diabetes mellitus; HbA_1c = glycated hemoglobin; IFCC = International Federation of Clinical Chemistry.
Note: All indicators within the previous 15 months except for DM18 (immunization in the preceding September 1 to March 31).